Anew Medical to Advance Klotho Gene Therapy Program for Neurodegenerative Disorders; Shares Rise

MT Newswires Live

2024-07-09

Anew Medical to Advance Klotho Gene Therapy Program for Neurodegenerative Disorders; Shares Rise

Anew Medical (WENA) said Tuesday it plans to advance its patented Klotho gene therapy program for neurodegenerative disorders.

Anew said it has "compelling initial data" suggesting that elevated levels of Klotho contributes to longer, healthier lifespans, while people with depleted levels of the gene "are more susceptible to neurodegenerative disorders such as ALS, Alzheimer's, and Parkinson's Disease."

The company said it plans to advance its program in clinical trials, in the commercialization of a diagnostic that will enable doctors to quantify levels of Klotho gene and protein isoforms in blood samples, and in age-related disorders such as memory loss, osteoporosis, and sarcopenia.

Anew Medical rose 48% to $2.14 in premarket trading.

Price: 2.3800, Change: +0.93, Percent Change: +64.14

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2450404553"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2450404553\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2450404553?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-07-09 19:42","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2450404553","market":"nz","top_or_hot":-1,"title":"Anew Medical to Advance Klotho Gene Therapy Program for Neurodegenerative Disorders; Shares Rise","media":"MT Newswires Live","content":"<html><body><p>Anew Medical to Advance Klotho Gene Therapy Program for Neurodegenerative Disorders; Shares Rise</p><p> Anew Medical (WENA) said Tuesday it plans to advance its patented Klotho gene therapy program for neurodegenerative disorders.</p><p>Anew said it has \"compelling initial data\" suggesting that elevated levels of Klotho contributes to longer, healthier lifespans, while people with depleted levels of the gene \"are more susceptible to neurodegenerative disorders such as ALS, Alzheimer's, and Parkinson's Disease.\"</p><p>The company said it plans to advance its program in  clinical trials, in the commercialization of a diagnostic that will enable doctors to quantify levels of Klotho gene and protein isoforms in blood samples, and in age-related disorders such as memory loss, osteoporosis, and sarcopenia.</p><p>Anew Medical rose 48% to $2.14 in premarket trading.</p><p>Price: 2.3800, Change: +0.93, Percent Change: +64.14</p></body></html>","source":"mtnewswires_live","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Anew Medical to Advance Klotho Gene Therapy Program for Neurodegenerative Disorders; Shares Rise</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAnew Medical to Advance Klotho Gene Therapy Program for Neurodegenerative Disorders; Shares Rise\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-07-09 19:42 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Anew Medical to Advance Klotho Gene Therapy Program for Neurodegenerative Disorders; Shares Rise Anew Medical (WENA) said Tuesday it plans to advance its patented Klotho gene therapy program for ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OTS.SI","symbol_name":"OTS Holdings","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2450404553","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2450404553","pubTimestamp":1720525366,"columns":[],"sourceInfo":{"source_id":"mtnewswires_live","name":"MT Newswires Live"},"weMediaInfo":null,"summary":"Anew Medical to Advance Klotho Gene Therapy Program for Neurodegenerative Disorders; Shares Rise Ane","collect":0,"end_time":0,"defaultTopTitle":"mtnewswires.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"OTS.SI":"OTS Holdings","BK4164":"特殊金融服务"},"translate_title":"Anew Medical推进Klotho神经退行性疾病基因治疗计划；股价上涨","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OTS.SI":1,"WENA":1},"content_text":"Anew Medical to Advance Klotho Gene Therapy Program for Neurodegenerative Disorders; Shares Rise Anew Medical (WENA) said Tuesday it plans to advance its patented Klotho gene therapy program for neurodegenerative disorders.Anew said it has \"compelling initial data\" suggesting that elevated levels of Klotho contributes to longer, healthier lifespans, while people with depleted levels of the gene \"are more susceptible to neurodegenerative disorders such as ALS, Alzheimer's, and Parkinson's Disease.\"The company said it plans to advance its program in  clinical trials, in the commercialization of a diagnostic that will enable doctors to quantify levels of Klotho gene and protein isoforms in blood samples, and in age-related disorders such as memory loss, osteoporosis, and sarcopenia.Anew Medical rose 48% to $2.14 in premarket trading.Price: 2.3800, Change: +0.93, Percent Change: +64.14","kind":"live","is_publish_news":false,"is_publish_highlight":false,"is_publish_live":true,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"code":"91000000","status":"200"}}}